Humane Genomics

Humane Genomics is a synthetic biology company dedicated to developing personalized oncolytic virus therapies for the treatment of cancer. The company utilizes a proprietary platform that combines DNA synthesis and yeast-based assembly to design and build synthetic viruses from the ground up. This approach allows for the rapid creation of viruses tailored to target specific mutations within a patient's tumor, potentially increasing efficacy while minimizing side effects. By treating the virus as software that can be programmed, Humane Genomics aims to transform cancer treatment into a precise and scalable digital-to-biological process. Their current focus is on advancing their synthetic virus platform through pre-clinical development for various solid tumor indications.